Amneal Pharmaceuticals (AMRX) Deferred Taxes (2017 - 2019)

Amneal Pharmaceuticals' Deferred Taxes history runs 3 years deep, the most recent figure standing at $33000.0 for Q4 2019.

• In Q4 2019, Deferred Taxes rose 110.06% year-over-year to $33000.0; the TTM figure through Sep 2020 stood at $33000.0 (down 99.99% YoY), while the FY2019 annual figure was $371.7 million, up 4038.09% from the prior year.
• Deferred Taxes was $33000.0 for Q4 2019 at Amneal Pharmaceuticals, down from $389.9 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $389.9 million in Q3 2019 to a low of -$14.5 million in Q2 2018.
• Historically, Deferred Taxes has averaged $36.3 million across 3 years, with a median of -$420000.0 in 2018.
• Biggest YoY gain for Deferred Taxes was 6528.56% in 2019; the steepest drop was 1830.47% in 2019.
• A 3-year view of Deferred Taxes shows it stood at $1.3 million in 2017, then plunged by 125.71% to -$328000.0 in 2018, then surged by 110.06% to $33000.0 in 2019.
• The last three Deferred Taxes figures came in at $33000.0 (Q4 2019), $389.9 million (Q3 2019), and -$8.3 million (Q2 2019), per Business Quant data.